Dr Nadeau presented review of new immunotherapy for treating food allergy. Potential food allergy therapies in this slide: https://t.co/N00tHOvHIh
AR101 - 100% of patients tolerated 443g (2 peanuts) and 78% tolerated the challenge (equivalent to 1g or a peanut butter cookie) https://t.co/3QYxFVtOBO
Possible biologics for peanut allergy in this slide: https://t.co/GkO3TStDge
There is evidence the prevalence of peanut #allergy is not on the rise from comparison of longitudinal cohorts https://t.co/Ds28rZ83Cm
LEAP study: Peanut recommended to be introduced starting around 4-6 months https://t.co/ccs9HulMbz
Guidelines for peanut introduction changing. Introduce early, test if indicated. https://t.co/6MkSc8VE8Q
Peanut allergy guideline coming out Jan 2017 https://t.co/ccOjJbOyvm
However, does LEAP study applies to other foods? Early egg introduction has mixed evidence, trend towards benefit in non-eczema group but towards harm in eczema group. Very mixed picture when it comes to using hydrolyzed formula vs cow's milk formula in eczema. No clear benefit.
Socioeconomic disparity in food allergy: https://t.co/oVTh9SIKlw
Income and race influence how we utilize healthcare and incur costs: https://t.co/ZIn8WSOgDV
This is a Twitter summary from #ACAAI16 meeting. The post is a part of series. See the rest here: http://allergynotes.blogspot.com/search/label/#ACAAI16
Several allergists did a great job posting updates on Twitter from the 2016 meeting of ACAAI, the hashtag was #ACAAI16. I used the website Symplur to review the tweets:
@docalergias @drstanfineman @drsilge
Presentation handouts are available from the ACAAI website: http://annualmeeting.acaai.org/session_presentations.cfm
Adverse Food Reactions (click to enlarge the image).